Mathers, CD, Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med
2006; 3: e442.
Farmer, A, Korszun, A, Owen, MJ, Craddock, N, Jones, L, Jones, I, et al. Medical disorders in people with recurrent depression. Br J Psychiatry
2008; 192: 351–5.
Afari, N, Noonan, C, Goldberg, J, Roy-Byrne, P, Schur, E, Golnari, G, et al. Depression and obesity: do shared genes explain the relationship?
2010; 27: 799–806.
Luppino, FS, de Wit, LM, Bouvy, PF, Stijnen, T, Cuijpers, P, Penninx, BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry
2010; 67: 220–9.
Loos, RJ, Bouchard, C. FTO: the first gene contributing to common forms of human obesity. Obes Rev
2008; 9: 246–50.
Frayling, TM, Timpson, NJ, Weedon, MN, Zeqqini, E, Frealthy, RM, Lindgren, CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science
2007; 316: 889–94.
Dina, C, Meyre, D, Gallina, S, Durand, E, Körner, A, Jacobson, P, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet
2007; 39: 724–6.
Cotsapas, C, Speliotes, EK, Hatoum, IJ, Greenawalt, DM, Dobrin, T, Lum, PY, et al. Common body mass index-associated variants confer risk of extreme obesity. Hum Mol Genet
2009; 18: 3502–7.
Hinney, A, Nguyen, TT, Scherag, A, Friedel, S, Brönner, G, Müller, TD, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLOS ONE
2007; 2: e1361.
Fawcett, KA, Barroso, I. The genetics of obesity: FTO leads the way. Trends Genet
2010; 26: 266–74.
Scuteri, A, Sanna, S, Chen, WM, Uda, M, Albai, G, Strait, J, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet
2007; 3: e115.
Speliotes, EK, Wilier, CJ, Berndt, SI, Monda, KL, Thorleifsson, G, Jackson, ALL, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet
2010; 42: 937–48.
Thorleifsson, G, Walters, GB, Gudbjartsson, DF, Steinthorsdottir, V, Sulem, P, Helgadottir, A, et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet
2009; 41: 18–24.
Gerken, T, Girard, CA, Tung, YC, Webby, CJ, Saudek, V, Hewitson, KS, et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science
2007; 318: 1469–72.
Cecil, JE, Tavendale, R, Watt, P, Hetherington, MM, Palmer, CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med
2008; 359: 2558–66.
Wardle, J, Carnell, S, Haworth, CM, Farooqi, IS, O'Rahilly, S, Plomin, R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab
2008; 93: 3640–3.
Cole, JH, Boyle, CP, Simmons, A, Cohen-Woods, S, Rivera, M, McGuffin, P, et al. Body mass index, but not FTO genotype or major depressive disorder, influences brain structure. Neuroscience
2013; 252: 109–17.
Ho, AJ, Stein, JL, Hua, X, Lee, S, Hibar, DP, Leow, AD, et al. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci
2010; 107: 8404–9.
Rivera, M, Cohen-Woods, S, Kapur, K, Breen, G, Ng, MY, Butler, AW, et al. Depressive disorder moderates the effect of the FTO gene on body mass index. Mol Psychiatry
2012; 17: 604–11.
Cohen-Woods, S, Gaysina, D, Craddock, N, Farmer, A, Gray, J, Gunasinghe, C, et al. Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder. Hum Mol Genet
2009; 18: 1504–9.
Farmer, A, Breen, G, Brewster, S, Craddock, N, Gill, M, Korszun, A, et al. The Depression Network (DeNT) Study: methodology and sociodemographic characteristics of the first 470 affected sibling pairs from a large multi-site linkage genetic study. BMC Psychiatry
2004; 4: 42.
McGuffin, P, Knight, J, Breen, G, Brewster, S, Boyd, PR, Craddock, N, et al. Whole genome linkage scan of recurrent depressive disorder from the depression network study. Hum Mol Genet
2005; 14: 3337–45.
Uher, R, Huezo-Diaz, P, Perroud, N, Smith, R, Rietschel, M, Mors, O, et al. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J
2009; 9: 225–33.
Wing, JK, Babor, T, Brugha, T, Burke, J, Cooper, JE, Giel, R, et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry
1990; 47: 589–93.
McGuffin, P, Katz, R, Aldrich, J. Past and present state examination: the assessment of ‘lifetime ever’ psychopathology. Psychol Med
1986; 16: 461–5.
Firmann, M, Mayor, V, Vidal, PM, Bochud, M, Pécoud, A, Hayoz, D, et al. The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord
2008; 8: 6.
Preisig, M, Waeber, G, Vollenweider, P, Bovet, P, Rothen, S, Vandeleur, C, et al. The PsyCoLaus study: methodology and characteristics of the sample of a population-based survey on psychiatric disorders and their association with genetic and cardiovascular risk factors. BMC Psychiatry
2009; 9: 9.
Nurnberger, JI Jr, Blehar, MC, Kaufmann, CA, York-Cooler, C, Simpson, SG, Harkavy-Friedman, J, et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry
1994; 51: 849–59.
Lucae, S, Salyakina, D, Barden, N, Harvey, M, Gagné, B, Labbé, M, et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet
2006; 15: 2438–45.
Hennings, JM, Owashi, T, Binder, EB, Horstmann, S, Menke, A, Kloiber, S, et al. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res
2009; 43: 215–29.
Penninx, BW, Beekman, AT, Smit, JH, Zitman, FG, Nolen, WA, Spinhoven, P, et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods, Int J Methods Psychiatr Res
2008; 17: 121–40.
Willemsen, G, de Geus, EJ, Bartels, M, van Beijsterveldt, CE, Brooks, AL, Estourgie-van Burk, GF, et al. The Netherlands Twin Register biobank: a resource for genetic epidemiological studies. Twin Res Hum Genet
2010; 13: 231–45.
Ter Smitten, MH, Smeets, RMW, Van der Brink, W. Composite International Diagnostic Interview (CIDI), Version 2.1, 12-Months.
World Health Organization, 1998.
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatr
2013; 18: 497–511.
Lewis, CM, Ng, MY, Butler, AW, Cohen-Woods, S, Uher, R, Pirlo, K, et al. Genome-wide association study of major recurrent depression in the UK population. Am J Psychiatry
2010; 167: 949–57.
Ising, M, Lucae, S, Binder, EB, Bettecken, T, Uhr, M, Ripke, S, et al. A genome-wide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry
2009; 66: 966–75.
Nivard, MG, Mbarek, H, Hottenga, JJ, Smit, JH, Jansen, R, Penninx, BW, et al. Further confirmation of the association between anxiety and CTNND2: replication in humans. Genes Brain Behav
2014; 13: 195–201.
Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MA, Bender, D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet
2007; 81: 559–75.
Han, B, Eskin, E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am J Hum Gen
2011; 88: 586–98.
Penninx, BW, Milaneschi, Y, Lamers, F, Vogelzangs, N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med
2013; 11: 129.
Lamers, F, Vogelzangs, N, Merikangas, KR, de Jonge, P, Beekman, AT, Penninx, BW. Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry
2013; 18: 692–9.
Green, MA, Scott, NA, Cross, SE, Liao, KY, Hallengren, JJ, Davids, CM, et al. Eating disorder behaviors and depression: a minimal relationship beyond social comparison, self-esteem, and body dissatisfaction. J Clin Psychol
2009; 65: 989–99.
Friedman, KE, Reichmann, SK, Costanzo, PR, Zelli, A, Ashmore, JA, Musante, GJ. Weight stigmatization and ideological beliefs: relation to psychological functioning in obese adults. Obes Res
2005; 13: 907–16.